Combined action of vasoactive amines and bradykinin mediates allergen-evoked thermal hyperalgesia in rats

European Journal of Pharmacology

Volumn 462, Issue 1-3, 2003, Pages 185-192

  Lavich, Tatiana R ^a   Cordeiro, Renato S B ^a   Calixto, João B ^b   E Silva, Patrícia M R ^a   Martins, Marco A ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Allergy; Bradykinin; Hyperalgesia; Inflammation; Vasoactive amine

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; BOVINE SERUM ALBUMIN; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ DERIVATIVE; CYPROHEPTADINE; HISTAMINE; ICATIBANT; IMMUNOGLOBULIN E; MECLOZINE; METHYSERGIDE; MONOCLONAL ANTIBODY; SEROTONIN; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FOOT; HYPERALGESIA; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; SENSITIZATION; TEMPERATURE;

EID: 0037458678     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02947-3     Document Type: Article

References (39)

1. Abraham W.M., Burch R.M., Farmer S.G., Sielczak M.W., Ahmed A., Cortes A. A bradykinin antagonist modifies allergen-induced mediator release and late bronchial responses in sheep. Am. Rev. Respir. Dis. 143:1991;787-796.
2. Bandeira-Melo C., Calheiros A.S., Silva P.M., Cordeiro R.S., Teixeira M.M., Martins M.A. Suppressive effect of distinct bradykinin B2 receptor antagonist on allergen-evoked exudation and leukocyte infiltration in sensitized rats. Br. J. Pharmacol. 127:1999;315-320.
3. Banik R.K., Kozaki Y., Sato J., Gera L., Mizumura K. B2 receptor-mediated enhanced bradykinin sensitivity of rat cutaneous C-fiber nociceptors during persistent inflammation. J. Neurophysiol. 86:2001;2727-2735.
4. Besson J.M. The complexity of physiopharmacologic aspects of pain. Drugs. 53(Suppl. 2):1997;1-9.
5. Busse W.W., Lemanske R.F. Jr. Asthma. N. Engl. J. Med. 344:2001;350-362.
6. Calixto J.B., Cabrini D.A., Ferreira J., Campos M.M. Kinins in pain and inflammation. Pain. 87:2000;1-5.
7. Castro-Faria-Neto H.C., Bozza P.T., Silva A.R., Silva P.M., Lima M.C., Martins M.A., Cordeiro R.S., Vargaftig B.B. Interference of azelastine with anaphylaxis induced by ovalbumin challenge in actively sensitized rats. Eur. J. Pharmacol. 213:1992;183-188.
8. Coelho M.M., Oliveira C.R., Pajolla G.P., Calixto J.B., Pela I.R. Central involvement of kinin B1 and B2 receptors in the febrile response induced by endotoxin in rats. Br. J. Pharmacol. 121:1997;296-302.
9. Davis A.J., Perkins M.N. Induction of B1 receptors in vivo in a model of persistent inflammatory mechanical hyperalgesia in the rat. Neuropharmacology. 33:1994;127-133.
10. Davis A.J., Perkins M.N. The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat. Br. J. Pharmacol. 113:1994;63-68.
11. Douglas W.W. Autacoids. Gilman G.A., Goodman L.S., Rall T.W., Murad F. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 7th ed. 1985;604-638 MacMillan, New York, NY.
12. Feletou M., Germain M., Thurieau C., Fauchere J.L., Canet E. Agonistic and antagonistic properties of the bradykinin B2 receptor antagonist, Hoe 140, in isolated blood vessels from different species. Br. J. Pharmacol. 112:1994;683-689.
13. Ferreira S.H., Lorenzetti B.B., Correa F.M. Central and peripheral antialgesic action of aspirin-like drugs. Eur. J. Pharmacol. 53:1978;39-48.
14. Ferreira J., Campos M.M., Pesquero J.B., Araujo R.C., Bader M., Calixto J.B. Evidence for the participation of kinins in Freund's adjuvant-induced inflammatory and nociceptive responses in kinin B1 and B2 receptor knockout mice. Neuropharmacology. 41:2001;1006-1012.
15. Gilfoil T.M., Klavins I. 5-Hydroxytryptamine, bradykinin, and histamine as mediators of inflammatory hyperesthesia. Am. J. Physiol. 208:1965;867-876.
16. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
17. Heyer G.R., Hornstein O.P. Recent studies of cutaneous nociception in atopic and non-atopic subjects. J. Dermatol. 26:1999;77-86.
18. Heyer G., Koppert W., Martus P., Handwerker H.O. Histamine and cutaneous nociception: histamine-induced responses in patients with atopic eczema, psoriasis and urticaria. Acta Derm.-Venereol. 78:1998;123-126.
19. Hock F.J., Wirth K., Albus U., Linz W., Gerhards H.J., Wiemer G., Henke S., Breipohl G., Konig W., Knolle J.et al. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol. 102:1991;769-773.
20. Hogan M.B., Harris K.E., Protter A.A., Patterson R. A bradykinin antagonist inhibits both bradykinin-and the allergen-induced airway response in primates. Proc. Assoc. Am. Physicians. 109:1997;269-274.
21. Kay A.B. Allergy and allergic diseases. First of two parts. N. Engl. J. Med. 344:2001;30-37.
22. Lima M.C., Chagas M.S., Silva P.M., Calheiros A.S., Prouvost-Danon A., Fari-Neto H.C., Cordeiro R.S., Martins M.A. Histamine-potentiating activity in rat anaphylactic pleural fluid: role of serotonin. Braz. J. Med. Biol. Res. 29:1996;1049-1056.
23. Mylecharane E.J. The classification of 5-hydroxytryptamine receptors. Clin. Exp. Pharmacol. Physiol. 16:1989;517-522.
24. Parada C.A., Tambeli C.H., Cunha F.Q., Ferreira S.H. The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience. 102:2001;937-944.
25. Petersen M., Eckert A.S., Segond von Banchet G., Heppelmann B., Klusch A., Kniffki K.D. Plasticity in the expression of bradykinin binding sites in sensory neurons after mechanical nerve injury. Neuroscience. 83:1998;949-959.
26. Poole S., Lorenzetti B.B., Cunha J.M., Cunha F.Q., Ferreira S.H. Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia. Br. J. Pharmacol. 126:1999;649-656.
27. Proud D., Togias A., Naclerio R.M., Crush S.A., Norman P.S., Lichtenstein L.M. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J. Clin. Invest. 72:1983;1678-1685.
28. Regoli D., Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32:1980;1-46.
29. Rukwied R., Heyer G. Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients. Exp. Dermatol. 8:1999;39-45.
30. Shirasaki H., Kojima T., Asakura K., Kataura A., Shimamoto K., Limura O. The pathophysiological role of kinin and chemical mediators on experimental allergic rhinitis. Adv. Exp. Med. Biol. 247A:1989;375-378.
31. Sicuteri F., Fanciullacci M., Del Bianco P.L. Vasoneuroactive substances as mediators of vascular pain. Mal. Cardiovasc. 6:1965;505-530.
32. Siegmund F., Cadmus R., Lu G. A method for evaluating both non-narcotic and narcotic analgesics. Proc. Soc. Exp. Biol. Med. 95:1957;729.
33. Stewart J.M., Gera L., York E.J., Chan D.C., Bunn P. Bradykinin antagonists: present progress and future prospects. Immunopharmacology. 43:1999;155-161.
34. Stosh V.I., Shugailov I.A., Moskovets O.N., Shul'gin E.G., Myl'nikov A.V. Characteristics of the pain sensitivity in patients with accompanying allergic diseases prior to stomatologic surgery. Anesteziol. Reanimatol. 1991;31-34.
35. Tonussi C.R., Ferreira S.H. Bradykinin-induced knee joint incapacitation involves bradykinin B2 receptor mediated hyperalgesia and bradykinin B1 receptor-mediated nociception. Eur. J. Pharmacol. 326:1997;61-65.
36. Turner P., Dear J., Scadding G., Foreman J.C. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen. J. Allergy Clin. Immunol. 107:2001;105-113.
37. Van Arman C.G., Nuss G.W., Winter C.A., Flataker L. Proteolitic enzymes as mediators of pain. Lim R.K.S., Armstrong D., Pardo E.G. Pharmacology of Pain. 1968;25-32 Pergamon, Oxford.
38. Williams C.M., Galli S.J. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J. Allergy Clin. Immunol. 105:2000;847-859.
39. Wirth K., Hock F.J., Albus U., Linz W., Alpermann H.G., Anagnostopoulos H., Henk S., Breipohl G., Konig W., Knolle J.et al. Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br. J. Pharmacol. 102:1991;774-777.